Thank you. This leads into my next question.
Another concern that you've highlighted, in a paper you wrote on EU export controls, is with the authorization decisions. Even if vaccine shipments are authorized, in the end, these measures may add delays between the time of a shipment's being prepared and its then landing in the intended country.
What types of delays could Canada see in receiving vaccines versus those for a country that is specifically exempted from these types of measures?